Switzerland-based Basilea Pharmaceutica Ltd has filed a registration document with the US Securities and Exchange Commission (SEC) in preparation for a listing of its shares on the Nasdaq over-the-counter market. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
